CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Lidocaine Hydrochloride

LIDOCAINE HCI· ingredient lidocaineAmides· LIDOCAINE HYDROCHLORIDE 10 mg/mL; LIDOCAINE HYDROCHLORIDE 20 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.54764
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 7 weeks.

2025-09-172026-05-20

Same-ingredient options by acquisition cost

Other lidocaine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
Burn Relief$0.02792−$0.51970
ALCEMISTE$0.05101−$0.49660
Lidocaine Viscous$0.07984−$0.46780
Lidocaine$0.09024−$0.45740
lidocaine$0.15755−$0.39010
Cadira Compliant Blood Stat$0.21848−$0.32920
LIDOCAINE HCl$0.24343−$0.30420
Lidocaine$0.35160−$0.19600

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.